Zota Health Care Ltd. Share Price

Overview

Zota Health Care Ltd. share price is currently ₹1,263.80, down by - ₹42.12 (3.23%) from its previous closing price of ₹1,305.92. The share price has gained 13.95% over the past month and declined -15.74% over the past year. The stock's 52-week low and high are ₹1,005.41 and ₹1,710.89, respectively. Zota Health Care Ltd. has a market capitalisation of ₹ 4,450.29 Cr. The share price was last updated on 12 Oct 2026, 03:29 PM IST.

Zota Health Care Ltd.
Zota Health Care Ltd.
ZOTA
 ₹0.00
- ₹42.12
3.23%
Trading
 ₹0.00(%)1D

Updated: 12 Oct 2026, 03:29:51 pm IST

Market Data

Open Price

 ₹1,316.25

Prev. Close

 ₹1,305.92
 ₹1,259.50

Day Low

 ₹1,318.39

Day High

 ₹1,005.41

52 Week Low

 ₹1,710.89

52 Week High

TradingTrading
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-41.29

Sector PE

37.66

PB Ratio

6.31

Sector PB

4.29

EPS

-30.61

Dividend Yield

0.09

Today's Volume

15.012 K

5 Day Avg. Volume

59.998 K

PEG Ratio

4.92

Market Cap.

₹ 4,450.29 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 10% at ₹1/Share
21-Sep-202621-Sep-2026
DividendsFinal Dividend of 10% at ₹1/Share
22-Sep-202522-Sep-2025
DividendsFinal Dividend of 10% at ₹1/Share
20-Sep-202421-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
WhiteOak Capital Special Opportunities Fund - Regular Plan - Growth97.72 k
97.72 k
no change
WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth28.83 k
28.83 k
no change

About Zota Health Care Ltd. 👋

Zota Health Care Limited is an India-based pharmaceutical company, which is engaged in the manufacturing and marketing of pharmaceutical products catering to domestic and international markets. It engages in manufacturing, marketing, and exporting a range of pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company's business model comprises three verticals, namely Domestic, Exports, and Retail Pharmacy Chain. Its Domestic Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products. Its product portfolio offers over 4,000 therapeutic product categories such as generic, OTC products, allopathic, ayurvedic, and others. Its Retail Pharmacy Chain business operates under the Davaindia brand, which offers a range of private-label products that include pharmaceuticals, nutraceutical, OTC items, and ayurvedic treatments, with a focus on chronic disease management.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Vineet Saxena

Vineet Saxena

4 Jul • 9:52 PM · SEBI-Registered Analyst

Building Scale Through Affordable Healthcare

ZOTA

ZOTA
continues to strengthen its position in India's affordable healthcare space through the rapid expansion of its Davaindia pharmacy network. The company delivered robust revenue growth in its latest quarter, supported by strong store additions and healthy same-store sales. While profitability remains under pressure due to expansion-related investments, management remains focused on scaling the business with plans to add 500–700 new stores in FY27, taking the long-term network target beyond 5,000 stores. As a retail pharmacy business, Zota does not have a conventional order book; instead, its revenue visibility is driven by recurring demand across its expanding store network. Management remains optimistic about improving profitability through operating leverage as newly opened stores mature and by increasing the contribution of higher-margin private-label products. The strategy reflects a balance between aggressive expansion and sustainable earnings growth. With a market capitalisation of around ₹5,000 crore, investors should monitor store additions, same-store sales growth, margin expansion, and the path toward profitability, as these will be the key drivers of value creation over the coming years.

See More
Unite Technologies Financial

Unite Technologies Financial

30 Jun • 3:26 PM · SEBI-Registered Analyst

Technical Analysis Zota Health Care Ltd.

The stock

ZOTA
is saw a massive sustained uptrend starting from the 600 level eventually peaking near the 1700 mark. After hitting its all-time high the stock underwent a deep and healthy correction dropping down to find a floor in the 1050–1100 zone. The stock is currently in a strong recovery phase. Trading around 1415 it has bounced aggressively from its recent bottom. Immediate Support the 1300 area acts as a strong short-term base. If the stock experiences a minor pullback buyers are likely to step in here. Major Support the 1050–1100 level is a major demand zone. Immediate Resistance the next hurdle is the 1500 psychological level. Major Target if the stock breaks and sustains above 1500 the path clears to test the previous high near 1700. For short-term buyers entering near current levels or on minor dips toward 1300 offers an excellent risk-to-reward setup with an immediate target of 1500 and a strict stop-loss kept below 1300. Meanwhile current holders should comfortably maintain their positions as the stock demonstrates a strong V-shaped recovery and a structural shift back into an uptrend targeting the previous highs of 1700. Utilizing a trailing stop-loss around the 1200 zone is highly recommended to protect capital while giving the stock ample room to run and capture further bullish momentum.

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

26 Dec • 8:02 AM · SEBI-Registered Analyst

Zota Health Care shares in focus after ₹350 crore QIP by marquee investors

Zota Health Care has successfully raised ₹350 crore through a Qualified Institutional Placement (QIP). The funds were raised by allotting 22,80,130 equity shares at ₹1,535 per share to a group of marquee institutional investors, reflecting strong market confidence in the company. Key participants in the QIP include Valiant Partners, 360 ONE, 3P Investment Managers (led by Prashant Jain), White Oak Capital, Sanshi Fund I, and Turnaround Opportunities Fund, among others. This capital raise strengthens Zota Health Care’s balance sheet and provides resources to support future growth plans, expansion, and operational needs.

See More
Shashank Gupta

Shashank Gupta

24 Dec • 8:36 PM · SEBI-Registered Analyst

ZOTA
raises 350 crore through QIP

On December 24, 2025, Zota Health Care Limited, a leading generics pharmacy retailer in India, announced raising Rs 350 crores through a Qualified Institutional Placement (QIP) issue, allotting 22,80,130 equity shares at Rs 1,535 per share to prominent investors such as Valiant Partners, 360 ONE, and others. The funds will be utilized to expand its nationwide network of Davaindia stores, aiming to establish over 5,000 stores by March 2029, including Company-Owned Company-Operated (COCO) and Franchisee-Owned Franchisee-Operated (FOFO) models. Currently, Zota operates 2,253 Davaindia stores, offering affordable generic medicines to enhance accessibility. The company, listed on NSE, has been a key player in the Indian healthcare industry since 2000, specializing in pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products

See More
THREETREND RESEARCH

THREETREND RESEARCH

3 Dec • 8:20 AM · SEBI-Registered Analyst

The Most Impressive Earnings Performers in Small Caps! 📊 - Datamatics Global - R Systems International - Swaraj Engines - Kennametal India - VRL Logistics - Ashoka Buildcon - KNR Construction - Capillary Technologies - Electronics Mart - Goldiam International - Shoppers Stop - Pace Digitek - Refex Industries - Sunflag Iron - Goodluck India - Borosil - Aarti Drugs - Innova Captab - Zota Health Care - Suven Life Sciences

SUVEN

See More
Stock Reader

Stock Reader

16 Nov • 10:32 AM · SEBI-Registered Analyst

Zota Healthcare Ltd is a Delhi/Gujarat-based pharmaceutical company founded in 2000, focused on developing, manufacturing.

ZOTA
Their portfolio includes generic formulations, ayurvedic and nutraceuticals, and over-the-counter products. The business is structured around three verticals: domestic marketing, export, and retail pharmacy (their own chain Davaindia). They operate a wide distribution network across India (~1,050+ direct distributors) and export to more than 20+ countries globally. Zota’s manufacturing facility is based in Surat SEZ, and their R&D team has filed for multiple patents, enabling them to bring differentiated generic products to market. They also run a fast-growing pharmacy chain, Davaindia, with over ~1,500 stores, making healthcare more accessible at affordable pricing. Recently, Zota appointed Suniel Shetty as its brand ambassador to boost visibility and trust in its mission to deliver quality healthcare at low cost. In short, Zota Healthcare aims to be a one-stop solution in affordable healthcare — combining its pharma manufacturing, deep distribution, and retail chain — to serve patients across India and abroad.

See More

Frequently Asked Questions

What is the share price of Zota Health Care Ltd.?

What is the market cap of Zota Health Care Ltd.?

Should I buy Zota Health Care Ltd. stock now?

What is the 52 week high and low of Zota Health Care Ltd.?

Is the Zota Health Care Ltd. stock good to buy?

Is Zota Health Care Ltd. a good buy for the long term?

Is Zota Health Care Ltd. overvalued or undervalued?

What is the PE and PB ratio of Zota Health Care Ltd.?

Begin your investment journey today
Login/Register
What's Moving?

Today's market leaders and laggards

CP Capital Ltd.

CP Capital Ltd.

CPCAP

₹174.61

+31.19 (21.75%)

West Coast Paper Mills Ltd.

West Coast Paper Mills Ltd.

WSTCSTPAPR

₹868.54

+149.86 (20.85%)

Gallantt Ispat Ltd.

Gallantt Ispat Ltd.

GALLANTT

₹592.62

+98.25 (19.87%)

The New India Assurance Company Ltd.

The New India Assurance Company Ltd.

NIACL

₹186.32

+26.82 (16.82%)

Mawana Sugars Ltd.

Mawana Sugars Ltd.

MAWANASUG

₹166.61

+21.42 (14.75%)

Today's top moversExplore all →
Start Now